HEATHER WOODS: Open Payments
NPI 1639329105 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,512 in 27 payments from 10 companies in 2025. Trend: 2023 $346 · 2024 $576 · 2025 $2,512
Consulting: $1,535Food & beverage: $860Education: $86Travel & lodging: $32
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $1,622 |
| SANOFI-AVENTIS U.S. LLC | 9 | $401 |
| Alexion Pharmaceuticals, Inc. | 1 | $175 |
| SOBI, INC | 2 | $106 |
| Amgen Inc. | 1 | $98 |
| GENZYME CORPORATION | 2 | $39 |
| Incyte Corporation | 1 | $21 |
| Janssen Scientific Affairs, LLC | 2 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
Products named: TALVEY, REZUROCK, ULTOMIRIS, BLINCYTO, SARCLISA, NIKTIMVO, Doptelet, BLENREP.
Industry payments across PA — which companies pay providers there.
